GILD

Aethlon Medical Expands Clinical Network Through DaVita Agreement

[Accesswire] – Aethlon Medical, Inc. (OTC: AEMD), the pioneer in developing selective therapeutic filtration devices to address infectious disease, cancer and other life-threatening conditions, recently signed an agreement … moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]

February 26, 2014 Bystocknews GILD, stock Comments Off read more

Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26

[Business Wire] – Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the RBC Capital Markets 2014 Global Healthcare Conference in New York. moreView todays social media effects on GILDView the latest stocks trending across Twitter. Click to view dashboardSee who Gilead is hiring next, click here to view […]

February 25, 2014 Bystocknews GILD, stock Comments Off read more

Aethlon Medical Expands Clinical Network Through DaVita Agreement

Gilead Sciences to Present at the RBC Capital Markets 2014 Global Healthcare Conference on Wednesday, February 26

InterMune Reports Successful Trial for Lung Disease Drug

3 Things to Watch at Gilead

Pharmacyclics Attains 52-Week High

3 Healthcare Stocks Making News: Soligenix, Pharmacyclics, & Gilead

Gilead Sciences Inc. Still Offers 20%+ Upside In 2014

Gilead’s Hepatitis C Pill Takes Off Like A Rocket

Gilead Sciences, Inc on Its Way to Dominating Its Second Multibillion-Dollar Market

April 4th Options Now Available For Gilead Sciences (GILD)